General Information of the Compound
Compound ID
CP0496888
Compound Name
4-(6-Chloro-pyridazin-3-yl)-piperazine-1-carboxylic acid (4-trifluoromethyl-phenyl)-amide
    Show/Hide
Structure
Formula
C16H15ClF3N5O
Molecular Weight
385.777
Canonical SMILES
FC(F)(F)c1ccc(NC(=O)N2CCN(CC2)c2ccc(Cl)nn2)cc1
    Show/Hide
InChI
InChI=1S/C16H15ClF3N5O/c17-13-5-6-14(23-22-13)24-7-9-25(10-8-24)15(26)21-12-3-1-11(2-4-12)16(18,19)20/h1-6H,7-10H2,(H,21,26)
    Show/Hide
InChIKey
BNTXFVQWVFDMGM-UHFFFAOYSA-N
Physicochemical Property
logP
3.5029
Rotatable Bonds
2
Heavy Atom Count
26
Polar Areas
61.36
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
4
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 44396118
ChEMBL ID
CHEMBL186428
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS